Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-09-14

Clinical Trial Update: A Study of Tadalafil in Men With Benign Prostatic Hyperplasia Symptoms Who Are Being Treated With Alpha Blockers [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing tadalafil for relief of Benign Prostatic Hyperplasia symptoms in men already treated with alpha blockers; results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TADALAFIL (TADALAFIL)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Benign Prostatic Hyperplasia | Phase 3 | Status: COMPLETED | Results posted: 2010-09-14